Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 496,304 | 344,865 | 358,328 | 161,900 | 341,246 |
| Marketable Securities | 331,487 | 252,652 | 173,850 | 217,271 | 96,850 |
| Receivables | 127,425 | 104,746 | 42,040 | N/A | N/A |
| Inventories | 40,475 | 26,508 | 6,985 | N/A | N/A |
| Income taxes - deferred | 14,006 | 1,617 | N/A | N/A | N/A |
| TOTAL | $1,024,602 | $742,045 | $587,909 | $383,779 | $442,267 |
| Non-Current Assets | |||||
| PPE Net | 150,776 | 155,168 | 161,202 | 161,684 | 112,355 |
| Investments And Advances | 128,066 | 152,114 | 61,954 | 4,621 | 64,371 |
| Other Non-Current Assets | 30,350 | 6,511 | 7,290 | 8,366 | 7,302 |
| TOTAL | $309,192 | $313,793 | $230,446 | $174,671 | $184,028 |
| Total Assets | $1,333,794 | $1,055,838 | $818,355 | $558,450 | $626,295 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,238 | 4,985 | 4,132 | 3,981 | 8,398 |
| Accrued Expenses | 97,933 | 95,793 | 27,488 | 23,305 | 16,297 |
| TOTAL | $102,942 | $101,995 | $33,094 | $28,847 | $25,736 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,292 | 7,463 | 6,620 | 7,372 | 6,983 |
| TOTAL | $11,292 | $7,463 | $6,620 | $7,372 | $6,983 |
| Total Liabilities | $114,234 | $109,458 | $39,714 | $36,219 | $32,719 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,232 | 28,806 | 28,293 | 25,764 | 25,208 |
| Retained earnings | 24,163 | -180,668 | -269,827 | -280,759 | -140,784 |
| Other shareholders' equity | 1,136 | -190 | 638 | -728 | -163 |
| TOTAL | $1,219,560 | $946,380 | $778,641 | $522,231 | $593,576 |
| Total Liabilities And Equity | $1,333,794 | $1,055,838 | $818,355 | $558,450 | $626,295 |